This inventor holds 1 USPTO granted patent. Top assignee: Cl Pharma Aktiengesellschaft. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Heimo Stroissnig: Innovator in Pharmaceutical Chemistry
Introduction
Heimo Stroissnig is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on piperazinylalkyl-3(2H)-pyridazinones. His research has the potential to impact various therapeutic applications.
Latest Patents
Heimo Stroissnig holds a patent for "Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents." This invention relates to new piperazinylalkyl-3(2H)-pyridazinones characterized by specific chemical formulas. The radicals in his invention can represent hydrogen, phenyl, benzyl, or (C1-C6)-alkyl, which may be unsubstituted or substituted multiple times by various functional groups. He has 1 patent to his name.
Career Highlights
Stroissnig's career is marked by his dedication to advancing pharmaceutical research. His work has been recognized for its innovative approach to drug development, particularly in the synthesis of new chemical compounds that could serve as therapeutic agents.
Collaborations
Heimo Stroissnig has collaborated with esteemed colleagues such as Heinz Blaschke and Harald Fellier. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Heimo Stroissnig's contributions to the field of pharmaceutical chemistry exemplify the spirit of innovation. His patent on piperazinylalkyl-3(2H)-pyridazinones showcases his commitment to advancing medical science. His work continues to inspire future research in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile